Showing results (1301-1310 of 1,862) with videos related to

Sort By:
Pageof 187
Chinese Herbal Medicines|May 6, 2024
Huangqi Guizhi Wuwu Decoction suppresses inflammation and bone destruction in collagen-induced arthritis miceJiamin Bao, Yongjia Song, Minghui Hang, et al.
Eclinicalmedicine|December 21, 2023
Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trialAnxin Wang, Xue Tian, Xuewei Xie, et al.
International Angiology : a Journal of the International Union of Angiology|January 16, 2024
Predictors and outcomes of deep venous thrombosis in patients with acute ischemic stroke: results from the Chinese Stroke Center AllianceWeixin Cai, Ran Zhang, Yongjun Wang, et al.
Gut Microbes|September 17, 2024
Prebiotic inulin controls Th17 cells mediated central nervous system autoimmunity through modulating the gut microbiota and short chain fatty acidsNing Li, Xinyan Han, Ming Ruan, et al.
Applied Optics|March 4, 2024
DACNN-aided nonlinear equalizer for a probabilistic shaping coherent optical communication systemYuzhe Li, Huan Chang, Qi Zhang, et al.
Brain Sciences|October 28, 2023
Using the PEAR1 Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic AttackYanjie Xu, Dongxiao Yao, Weiqi Chen, et al.
Angiology|July 21, 2023
The Association Between the Fibrinogen-to-Albumin Ratio and Intracranial Arterial Stenosis in Patients With Acute Ischemic StrokeXiaoyu Wang, Yuesong Pan, Runhua Zhang, et al.
Neurological Research|September 19, 2023
Intracranial arterial stenosis and recurrence in stroke patients with different risk stratifications by Essen stroke risk scoreYue Suo, Jing Jing, Xia Meng, et al.
Stroke and Vascular Neurology|June 3, 2025
Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trialNanxing Wang, Meiyang Zhang, Mo Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2025
Behavioral Abnormalities, Cognitive Impairments, Synaptic Deficits, and Gene Replacement Therapy in a CRISPR Engineered Rat Model of 5p15.2 Deletion Associated With Cri du Chat SyndromeJingjing Shen, Yan Wang, Yang Liu, et al.
Pageof 187